153 related articles for article (PubMed ID: 10502765)
1. Use of T(2)-weighted susceptibility contrast MRI for mapping the blood volume in the glioma-bearing rat brain.
Le Duc G; Péoc'h M; Rémy C; Charpy O; Muller RN; Le Bas JF; Décorps M
Magn Reson Med; 1999 Oct; 42(4):754-61. PubMed ID: 10502765
[TBL] [Abstract][Full Text] [Related]
2. High resolution ultra high field magnetic resonance imaging of glioma microvascularity and hypoxia using ultra-small particles of iron oxide.
Christoforidis GA; Yang M; Kontzialis MS; Larson DG; Abduljalil A; Basso M; Yang W; Ray-Chaudhury A; Heverhagen J; Knopp MV; Barth RF
Invest Radiol; 2009 Jul; 44(7):375-83. PubMed ID: 19448552
[TBL] [Abstract][Full Text] [Related]
3. Vessel size imaging using low intravascular contrast agent concentrations.
Troprès I; Lamalle L; Farion R; Segebarth C; Rémy C
MAGMA; 2004 Dec; 17(3-6):313-6. PubMed ID: 15580376
[TBL] [Abstract][Full Text] [Related]
4. Cerebral blood volume quantification in a C6 tumor model using gadolinium per (3,6-anhydro) alpha-cyclodextrin as a new magnetic resonance imaging preclinical contrast agent.
Lahrech H; Perles-Barbacaru AT; Aous S; Le Bas JF; Debouzy JC; Gadelle A; Fries PH
J Cereb Blood Flow Metab; 2008 May; 28(5):1017-29. PubMed ID: 18183033
[TBL] [Abstract][Full Text] [Related]
5. [MRI monitoring ultra-small superparamagnetic iron oxide (USPIO) particle labeling C6 rat glioma cells].
Zhang GX; Li YJ; Zhang F; Zhao JL; Li KA; Hu YS
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(4):228-32. PubMed ID: 17425864
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of tumour vasculature in mouse brain by USPIO contrast-enhanced MRI.
Gambarota G; Leenders W; Maass C; Wesseling P; van der Kogel B; van Tellingen O; Heerschap A
Br J Cancer; 2008 Jun; 98(11):1784-9. PubMed ID: 18506183
[TBL] [Abstract][Full Text] [Related]
7. Vessel size index measurements in a rat model of glioma: comparison of the dynamic (Gd) and steady-state (iron-oxide) susceptibility contrast MRI approaches.
Pannetier N; Lemasson B; Christen T; Tachrount M; Troprès I; Farion R; Segebarth C; Rémy C; Barbier EL
NMR Biomed; 2012 Feb; 25(2):218-26. PubMed ID: 21751270
[TBL] [Abstract][Full Text] [Related]
8. Alterations of the Blood-Brain Barrier and Regional Perfusion in Tumor Development: MRI Insights from a Rat C6 Glioma Model.
Huhndorf M; Moussavi A; Kramann N; Will O; Hattermann K; Stadelmann C; Jansen O; Boretius S
PLoS One; 2016; 11(12):e0168174. PubMed ID: 28005983
[TBL] [Abstract][Full Text] [Related]
9. Characterization of tumor angiogenesis in rat brain using iron-based vessel size index MRI in combination with gadolinium-based dynamic contrast-enhanced MRI.
Beaumont M; Lemasson B; Farion R; Segebarth C; Rémy C; Barbier EL
J Cereb Blood Flow Metab; 2009 Oct; 29(10):1714-26. PubMed ID: 19584891
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging-based detection of glial brain tumors in mice after antiangiogenic treatment.
Claes A; Gambarota G; Hamans B; van Tellingen O; Wesseling P; Maass C; Heerschap A; Leenders W
Int J Cancer; 2008 May; 122(9):1981-6. PubMed ID: 18081012
[TBL] [Abstract][Full Text] [Related]
11. BOLD and CBV-weighted functional magnetic resonance imaging of the rat somatosensory system.
Keilholz SD; Silva AC; Raman M; Merkle H; Koretsky AP
Magn Reson Med; 2006 Feb; 55(2):316-24. PubMed ID: 16372281
[TBL] [Abstract][Full Text] [Related]
12. MR imaging of microvasculature.
Jensen JH; Chandra R
Magn Reson Med; 2000 Aug; 44(2):224-30. PubMed ID: 10918321
[TBL] [Abstract][Full Text] [Related]
13. In vivo assessment of tumoral angiogenesis.
Troprès I; Lamalle L; Péoc'h M; Farion R; Usson Y; Décorps M; Rémy C
Magn Reson Med; 2004 Mar; 51(3):533-41. PubMed ID: 15004795
[TBL] [Abstract][Full Text] [Related]
14. Impact of Software Modeling on the Accuracy of Perfusion MRI in Glioma.
Hu LS; Kelm Z; Korfiatis P; Dueck AC; Elrod C; Ellingson BM; Kaufmann TJ; Eschbacher JM; Karis JP; Smith K; Nakaji P; Brinkman D; Pafundi D; Baxter LC; Erickson BJ
AJNR Am J Neuroradiol; 2015 Dec; 36(12):2242-9. PubMed ID: 26359151
[TBL] [Abstract][Full Text] [Related]
15. Molecular susceptibility weighted imaging of the glioma rim in a mouse model.
Blasiak B; Landry J; Tyson R; Sharp J; Iqbal U; Abulrob A; Rushforth D; Matyas J; Ponjevic D; Sutherland GR; Wolfsberger S; Tomanek B
J Neurosci Methods; 2014 Apr; 226():132-138. PubMed ID: 24525326
[TBL] [Abstract][Full Text] [Related]
16. Vessel size imaging.
Troprès I; Grimault S; Vaeth A; Grillon E; Julien C; Payen JF; Lamalle L; Décorps M
Magn Reson Med; 2001 Mar; 45(3):397-408. PubMed ID: 11241696
[TBL] [Abstract][Full Text] [Related]
17. Quantifying the blood oxygenation level dependent effect in cerebral blood volume-weighted functional MRI at 9.4T.
Lu H; Scholl CA; Zuo Y; Stein EA; Yang Y
Magn Reson Med; 2007 Sep; 58(3):616-21. PubMed ID: 17763339
[TBL] [Abstract][Full Text] [Related]
18. MRI in acute cerebral ischaemia: perfusion imaging with superparamagnetic iron oxide in a rat model.
Forsting M; Reith W; Dörfler A; von Kummer R; Hacke W; Sartor K
Neuroradiology; 1994; 36(1):23-6. PubMed ID: 8107990
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility contrast magnetic resonance imaging determination of fractional tumor blood volume: a noninvasive imaging biomarker of response to the vascular disrupting agent ZD6126.
Robinson SP; Howe FA; Griffiths JR; Ryan AJ; Waterton JC
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):872-9. PubMed ID: 17889267
[TBL] [Abstract][Full Text] [Related]
20. Iron particles enhance visualization of experimental gliomas with high-resolution sonography.
Nolte I; Vince GH; Maurer M; Herbold C; Goldbrunner R; Solymosi L; Stoll G; Bendszus M
AJNR Am J Neuroradiol; 2005; 26(6):1469-74. PubMed ID: 15956517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
